INHIBIKASE THERAPEUTICS

Basic Information

3350 Riverwood Pkwy
Atlanta, GA, 30339-6451

http://inhibikase.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 828325899
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2


  1. System for multidimensional analysis of growth and migration of neurons and neuro

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Inhibikase Therapeutics is a clinical stage, biopharmaceutical company that has developed a host- targeted mechanism of action to treat AIDS-related and drug-induc ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. PML antiviral for AIDS

    Amount: $265,846.00

    DESCRIPTION (provided by applicant): Inhibikase Therapeutics is an early stage biopharmaceutical company developing a novel strategy for treating infectious disease that occurs in AIDS patients. The ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government